Skip to search formSkip to main contentSkip to account menu

Firdapse

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

3,4-diaminopyridine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
The possibility of obtaining marketing authorization of orphan pharmaceutical compounding preparations: 3,4‐DAP for Lambert‐Eaton Myasthenic Syndrome
2018
2018
3,4 DAP (FIRDAPSE) Improves Progressive Dok-7 Congenital Myasthenic Syndrome (CMS) Weakness: Clinical Experience in Two Patients (P6.452)
Objective: To describe treatment challenges in Dok-7 Congenital Myasthenic Syndrome (CMS) and clinical response to 3,4 DAP in two… 
2017
2017
Acetylator Status Impacts Amifampridine Phosphate (Firdapse™) Pharmacokinetics and Exposure to a Greater Extent Than Renal Function.
2015
2015
clinical And Jitter Changes During Oral Amifampridine Phosphate (firdapse : 169 ®: 169 ) Treatment In Congenital Myasthenic Syndrome : 169
2013
2013
Do we need authorized orphan drugs when compounded medications are available?
What is known and Objective:  Orphan drugs are used to diagnose, prevent or treat a rare disease. This Commentary aims to present… 
Review
2012
Review
2012
The Use of Aminopyridines in Neurological Disorders
AbstractAminopyridines are members of a family of monoamino and diamino derivatives of pyridine, and their principal mechanism of… 
2011
2011
Authors’ reply to BioMarin Europe
BioMarin Europe feels that our letter on the costs of orphan drugs such as amifampridine (Firdapse) for Lambert Eaton myasthenic… 
Review
2010
Review
2010
Government says it can’t review price of orphan drugs until end of 2013
The Department of Health for England has said it has no powers to control the price of amifampridine (marketed as Firdapse… 
Review
2010
Review
2010
Amifampridina (Firdapse®) per al tractament de la síndrome miastènica de Lambert Eaton
Amifampridina; Sindrome miastenica de Lambert Eaton; Revisio sistematica; Amifampridine; Lambert Eaton Myasthenic Syndrome… 
2010
2010
Amifampridine phosphate (Firdapse®) for Lambert-Eaton myasthenic syndrome
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)